Cetera Advisor Networks’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Cetera Advisor Networks’s Portfolio ZYNE Stock Details ZYNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-22,124	Closed	-$28.2K	–	2909
2023 Q3	$28.2K	Sell	22,124 -5,330	-19%	-$4.66K	﹤0.01%	2660
2023 Q2	$8.95K	Buy	27,454 +3,194	+13%	+$1.15K	﹤0.01%	2580
2023 Q1	$10.4K	Hold	24,260	–	–	﹤0.01%	2552
2022 Q4	$12.9K	Sell	24,260 -26	-0.1%	-$16	﹤0.01%	2502
2022 Q3	$18K	Sell	24,286 -119	-0.5%	-$135	﹤0.01%	2055
2022 Q2	$28K	Buy	+24,405	New	+$31.1K	﹤0.01%	2027

Cetera Advisor Networks's ZYNE Position: Q4 2023 in Review

Cetera Advisor Networks sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q4 2023, closing a stake of 22,124 shares — an estimated $28.2K sold.

Cetera Advisor Networks first reported a position in ZYNE in Q2 2022 and held it in 6 quarters. The position peaked at $28.2K in Q3 2023. 0 funds tracked by Wall St. Rank hold ZYNE as of Q4 2023.

Cetera Advisor Networks reported no remaining Zynerba Pharmaceuticals, Inc position as of Q4 2023 after selling out during the quarter.
Cetera Advisor Networks sold 22,124 Zynerba Pharmaceuticals, Inc shares in Q4 2023, an estimated $28.2K.
Cetera Advisor Networks first reported a position in Zynerba Pharmaceuticals, Inc in Q2 2022 and held it in 6 quarters.
Cetera Advisor Networks's Zynerba Pharmaceuticals, Inc position peaked at $28.2K in Q3 2023.
0 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q4 2023.

Based on Cetera Advisor Networks's 13F filing for Q4 2023, filed 13 Feb 2024.